Product Images Optiray 300

Optiray®320 is an iodine-based injectable contrast agent used for intravenous and intra-arterial use. It is only available with a prescription and must not be used for intrathecal use. The medication comes in a single-use syringe, which should be disposed of after use, and should be protected from light and stored at a temperature between 15°C to 30°C. The contents of the syringe contain 320 mg/mL of organically bound iodine, with an extra 78 mL of contrast medium. It is manufactured and distributed by Guerbet.*

Optiray 320 is an injectable medication that contains 320 mg/mL of organically bound iodine, primarily used for intravenous and intra-arterial administration. It should not be used for intrathecal purposes. The medication needs to be protected from high temperature and discarding a single-dose vial after use is recommended. The packaging includes information on the medication and patient safety guidelines. The text also includes the contents of the medication and instructions on storage and usage.*

Single Dose Container of Ioversol Injection 68%, which is organically bound. It is intended for intravenous and intra-arterial use only and is not suitable for intrathecal use. The medication and the injection pathway must be sterile. The unused portion and syringe must be discarded. It must be protected from light and stored at a controlled room temperature. The recommended dosage can vary depending on the medical indication and the patient's condition. This injection contains 73g of El, 3.6 mg of Europium, and 0.2 mg of Detterium. The manufacturer of this product is Guerbet.*

Single Dose Container containing Ioversol Injection 68% which is an organically bound iodine for Intravenous and Intra-arterial Use only. Not recommended for Intrathecal use. The medication and patient pathway should be sterile and the unused portion and syringe should be discarded after administration. It is important to protect from light and store at controlled room temperature. It contains 73g el 3.6mg e ufer and 02 mg dette and is produced by Guerbet. The recommended dosage should be determined for each indication.*

Optiray 350 is a medication containing 350 mg/mL of organically bound iodine used for intravenous and intra-arterial administration. It comes in a single-dose syringe and should be discarded if any unused portion remains. Optiray 350 is not recommended for intrathecal use. The recommended dosage of Optiray 350 and its administration should be determined by a healthcare professional. The medication should be stored below 25°C and protected from light. Lot and RAEON numbers for the medication are available. The text may contain some errors.*

This is a pharmaceutical product description for Optiray 350, a sterile solution for intravenous and intra-arterial use only, and is not intended for intrathecal use. The medication is contained in a single-dose container of 100mL and is organically bound to iodine. The recommended dosage will depend on the patient's condition and medical history, and proper safety precautions must be taken when administering this medication. The text also includes information on handling and storing the medication, as well as a warning to discard any unused portion of the syringe.*

Single Dose Container 125 mL of Optiray 350, a solution for intravenous and intra-arterial use only. Optiray 350 contains 74% loversol injection with 350 mg/mL of organically bound iodine. The medication and fluid pathway is aseptic. The single dose syringe should be discarded after use, and the unused portion should be taken out before the injection. The product should be protected from light and stored below 25°C. The recommended dosage should be strictly followed while using it. Manafactured by Guerbet.*